Impel NeuroPharma

Impel NeuroPharma

Impel NeuroPharma

Seattle-based Impel NeuroPharma was founded with a mission to enable drugs to bypass the blood brain barrier.
Founded
2008
Raised
$107.8M
Follow us
Alexa global traffic share
Twitter followers
06 Dec 2018
$67,500,000
Venture capital

Seattle biotech scores $67.5M to treat migraines and Parkinson’s with drugs delivered deep into the nasal cavity

GeekWire
+1
03 Dec 2016
$36,000,000
Venture capital (Series C)

Impel NeuroPharma raises $36M for drug delivery platform that bypasses blood-brain barrier

GeekWire
+1
29 Aug 2016
$1,090,000
Debt financing

SEC FORM D

sec
27 Nov 2013
$2,640,025
Venture capital
10 Aug 2012
$25,000
Debt financing
21 Oct 2011
$500,000
Venture capital (Series B)